GlobeNewswire: Primo Nutraceuticals Inc. Contains the last 10 of 55 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T09:20:35ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2021/04/14/2210301/0/en/Primo-Nutraceuticals-Inc-Corporate-Update.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc. Corporate Update2021-04-14T18:52:56Z<![CDATA[VANCOUVER, British Columbia, April 14, 2021 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("PRIMO" or the "Company") is announcing that the cease trade order issued by the British Columbia Securities Commission on December 4, 2020 was a result of the Company not filing its 2020 financial statements on time. During the audit process the Company’s auditor had embarked on an in-depth review of transactions that were the subject of previous audits and some extra time had been taken to accommodate the unexpected requests.]]>https://www.globenewswire.com/news-release/2020/11/12/2125709/0/en/Primo-Nutraceuticals-Inc-Enters-into-a-Binding-LOI-to-acquire-100-of-the-Assets-of-Full-Spectrum-Biosciences-Inc.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc. Enters into a Binding LOI to acquire 100% of the Assets of Full Spectrum Biosciences Inc.2020-11-12T14:00:00Z<![CDATA[VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF ) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (" PRIMO " or the "Company") is pleased to announce that it has signed a binding letter of intent (“LOI”) with Full Spectrum Biosciences Inc.(“FSB”),a Colorado company.]]>https://www.globenewswire.com/news-release/2020/10/21/2111786/0/en/Primo-Nutraceuticals-Inc-signs-a-Memorandum-of-Understanding-for-Exclusive-Rights-to-Sell-Rapid-Colloidal-Gold-Method-COVID-19-Test-Kits-in-Canada.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc. signs a Memorandum of Understanding for Exclusive Rights to Sell Rapid (Colloidal Gold Method) COVID-19 Test Kits in Canada2020-10-21T11:55:00Z<![CDATA[VANCOUVER, British Columbia, Oct. 21, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF ) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (" PRIMO " or the "Company") announces the signing of a Memorandum of Understanding (MOU) with Neo-Nostics ™ (Suzhou) Bioengineering Co. Ltd. Of Su Zhou City, China (“Neo-Nostics”) as the official trade representative for Neo-Nostics ™ with the exclusive rights to apply for licensing and to market and sell the following COVID-19 production Canada: Neo-Nostics ™ 2019-nCoV IgG/IgM Rapid Test Kit (Colloidal Gold Method) (Test Kit).]]>COVID-19 Test KitsCOVID-19 Test Kitshttps://www.globenewswire.com/news-release/2020/10/14/2108456/0/en/Primo-Nutraceuticals-Inc-Engages-MedCan-Biotechnologies-to-Conduct-Chemo-typing-Geno-typing-Studies-of-Psilocybin-Mushrooms.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc., Engages MedCan Biotechnologies to Conduct Chemo typing & Geno-typing Studies of Psilocybin Mushrooms2020-10-14T13:00:00Z<![CDATA[VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("PRIMO" or the "Company")]]>https://www.globenewswire.com/news-release/2020/10/01/2102253/0/en/Primo-Nutraceuticals-Inc-Signs-Letter-of-Intent-with-Brujera-Elixirs-Inc-to-Formulate-4-Innovative-Adaptogenic-Mushroom-Infused-Beverage-Products.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc. Signs Letter of Intent with Brujera Elixirs Inc. to Formulate 4 Innovative Adaptogenic Mushroom-Infused Beverage Products2020-10-01T13:00:00Z<![CDATA[VANCOUVER, British Columbia, Oct. 01, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("Primo Nutra" or the "Company") Further to the Company’s news release dated May 22, 2020 announcing that Primo Nutra received its Natural Product Number (“NPN) from Health Canada, the Company has decided to continue down that path by announcing that it has entered into a non-binding letter of intent (the "LOI") with Brujera Elixirs Inc. (“Brujera”) to formulate an exclusive line of 4 “Innovative adaptogenic mushroom-infused” beverage products for the natural health and wellness market.]]>https://www.globenewswire.com/news-release/2020/09/24/2098729/0/en/Primo-Nutraceuticals-Inc-and-Dan-Duquette-Former-MLB-Executive-Sign-Definitive-Agreement-to-Capitalize-on-Primo-Receiving-an-MDEL-License-from-Health-Canada-and-announces-Stock-Opt.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc. and Dan Duquette, Former MLB Executive, Sign Definitive Agreement to Capitalize on Primo Receiving an MDEL License from Health Canada and announces Stock Option Grant2020-09-24T13:00:00Z<![CDATA[VANCOUVER, British Columbia, Sept. 24, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("Primo" or the "Company") is pleased to announce that further to the Letter of Intent (the "LOI") with Duquette Consulting LLC ("Duquette Consulting“) referred to in the Company’s news release dated September 1, 2020 the Company has signed a Sales & Marketing Agreement to consummate the transaction.]]>https://www.globenewswire.com/news-release/2020/09/16/2094531/0/en/Primo-Nutraceuticals-Inc-receives-Medical-Device-Establishment-License-MDEL-from-Health-Canada.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc. receives Medical Device Establishment License (MDEL) from Health Canada2020-09-16T12:30:00Z<![CDATA[VANCOUVER, British Columbia, Sept. 16, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("Primo" or the "Company") is pleased to announce it has been issued a Medical Device Establishment License (“MDEL”) from Health Canada.]]>https://www.globenewswire.com/news-release/2020/09/01/2086939/0/en/Primo-Nutraceuticals-Inc-and-Dan-Duquette-Former-MLB-Executive-Enter-into-Letter-of-Intent-for-the-Development-of-a-Global-Supply-of-PPE-products-Primo-Hand-Sanitizer.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc. and Dan Duquette Former MLB Executive Enter into Letter of Intent for the Development of a Global Supply of PPE products & Primo Hand Sanitizer2020-09-01T12:30:00Z<![CDATA[VANCOUVER, British Columbia, Sept. 01, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("Primo" or the "Company") is pleased to announce it has entered into a Letter of Intent with Duquette Consulting LLC (the “LOI”), a company owned by Dan Duquette. Dan Duquette is a twice named Major League Baseball (MLB) Executive of the Year and former Executive Vice-President of the Baltimore Orioles, General Manager of the Montreal Expos, Boston Red Sox, and Milwaukee Brewers (https://en.wikipedia.org/wiki/Dan_Duquette). Dan Duquette has joined forces with Primo Nutraceuticals to partner in the development, sourcing and the global supply of personal protective equipment (“PPE”) products including Primo’s hand sanitizer.]]>https://www.globenewswire.com/news-release/2020/08/27/2085063/0/en/Primo-Nutraceuticals-Inc-Provides-Corporate-Update-Regarding-Operations-in-the-United-States-Distribution-of-Securities-for-Debt.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc. Provides Corporate Update Regarding Operations in the United States, Distribution of Securities for Debt2020-08-27T20:00:10Z<![CDATA[VANCOUVER, British Columbia, Aug. 27, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("Primo" or the "Company") is pleased to provide a management update for its Washington State and U.S. operations. Due to the COVID-19 pandemic and the closure of the Canada-U.S. border, the Company has suspended several of its U.S. operations except for the Oroville Campus.]]>https://www.globenewswire.com/news-release/2020/08/24/2082662/0/en/Primo-Nutraceuticals-Inc-Announces-Share-Consolidation.html?f=22&fvtc=4&fvtv=51278Primo Nutraceuticals Inc. Announces Share Consolidation2020-08-24T13:00:00Z<![CDATA[VANCOUVER, British Columbia, Aug. 24, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) ("Primo" or the "Company") is pleased to announce its intention to proceed with a share consolidation (the “Consolidation”) of its issued and outstanding common shares (“Common Shares”) on the basis of one (1) post-consolidation Common Share for every fifteen (15) pre-consolidation Common Shares.]]>